About hosting_84u3kt3n

This author has not yet filled in any details.
So far hosting_84u3kt3n has created 22 blog entries.

Mucomixx will be present at the Expodental Meeting in Rimini, from September 9 to 11

2021-08-18T13:30:26+00:00

Come and visit our Italian distributor Biosphaera at the stand Infodent. Expodental Meeting, the most important appointment of the year for Italian dental professionals. LOCATION/ Rimini Fiera (RN) PAVILIONS/ A1/2/3 - C1/2/3 ENTRANCE/ Porta SUD -

Mucomixx will be present at the Expodental Meeting in Rimini, from September 9 to 112021-08-18T13:30:26+00:00

Expodental Meeting

2020-04-01T14:01:07+00:00

The most important appointment of the year for italian dental professionals. LOCATION/ Rimini Fiera (RN) PAVILIONS/ A1/2/3 - C1/2/3 ENTRANCE/ Porta SUD - Via Emilia 155, Rimini DATE/ POSTPONED TO SEPTEMBER TIMETABLES/ Thursday and Saturday from

Expodental Meeting2020-04-01T14:01:07+00:00

Lactobacillus brevis CD2 for Prevention of Oral Mucositis in Patients With Head and Neck Tumors: A Multicentric Randomized Study.

2022-07-15T14:02:30+00:00

De Sanctis, V., Belgioia, L., Cante, D., La Porta, M. R., Caspiani, O., Guarnaccia, R., et al. Abstract BACKGROUND - Oropharyngeal mucositis occurs in virtually all patients with head and neck cancer receiving radiochemotherapy. The

Lactobacillus brevis CD2 for Prevention of Oral Mucositis in Patients With Head and Neck Tumors: A Multicentric Randomized Study.2022-07-15T14:02:30+00:00

Lactobacillus brevis CD2 lozenges prevent oral mucositis in patients undergoing high dose chemotherapy followed by haematopoietic stem cell transplantation

2022-07-15T14:41:32+00:00

Sharma, A., Rath, G. K., Chaudhary, S. P., Thakar, A., Mohanti, B. K., & Bahadur, S. Background Oral mucositis is a common inflammatory complication in patients undergoing high-dose chemotherapy and radiation followed by haematopoietic stem

Lactobacillus brevis CD2 lozenges prevent oral mucositis in patients undergoing high dose chemotherapy followed by haematopoietic stem cell transplantation2022-07-15T14:41:32+00:00

A Pilot Study on the Efficacy of Lactobacillus Brevis CD2 Lozenges in Preventing Oral Mucositis by High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation

2022-07-15T14:42:50+00:00

Giammarco, S., Chiusolo, P., Di Giovanni, A., Metafuni, E., Sica, S., Iavarone, F., et al. Abstract Treatment-induced oral mucositis (OM) is a pathological process characterized by mucosal damage, from mild inflammation to deep ulcerations and

A Pilot Study on the Efficacy of Lactobacillus Brevis CD2 Lozenges in Preventing Oral Mucositis by High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation2022-07-15T14:42:50+00:00

WORLD DAY OF ORAL HEALTH

2020-04-01T14:05:42+00:00

March 20th 2020 An anniversary wanted by FDI - World Dental Federation to incentivize people, communities and institutions to act to reduce the impact of oral diseases. The event involves over 70 countries around the

WORLD DAY OF ORAL HEALTH2020-04-01T14:05:42+00:00
© Copyright 2020- Mendes Srl - P.IVA 02102651003 - Via Nuoro, 12 - 00040 Ardea (RM)
Privacy Policy | Cookie Policy